| Role |
Name |
Disclosure |
Details |
| Author | David A Lederman, DMD, Chief, Oral Pathology Section, Department of Dentistry, Newark Beth Israel Medical Center; Director, Lakewood Pathology Associates | Nothing to disclose | Details | | Coauthor | Maria L Fornatora, DMD, Associate Professor, Departments of Oral and Maxillofacial Pathology, Medicine, and Surgery, Temple University School of Dentistry; Consulting Staff, Department of Oral and Maxillofacial Surgery, Temple University Hospital | Nothing to disclose | Details | | Medical Editor | Mark G Lebwohl, MD, Chairman, Department of Dermatology, Mount Sinai School of Medicine | Abbott Laboratories Actelion Amgen Astellas Basilea Briston-Myers Squibb Celtic Pharma Centocor Chattem DermiPsor DOV Galderma Genentech Genzyme Graceway Helix BioMedix Medicis Novartis OMP Pfizer PharmaDerm Stiefel Teva UCB Warner Chilcott Peplin Ranbaxy | Details | | Pharmacy Editor | Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA | Nothing to disclose | Details | | Managing Editor | Drore Eisen, MD, DDS, Consulting Staff, Department of Dermatology, Dermatology Research Associates of Cincinnati | Nothing to disclose | Details | | CME Editor | Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University | Nothing to disclose | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
|